SUVmax值与非小细胞肺癌放疗1年局部控制率关系研究
摘要
放疗是中晚期非小细胞肺癌（NSCLC）的主要治疗手段之一，根据放疗疗效制定个体化治疗方案对患者预后意义重大，但目前疗效评价手段效果都不够理想。随着NSCLC预后因素研究进展发现碳水化合物代谢程度是NSCLC独立预后因素之一，定量评价FDG代谢程度的SUVmax值与放疗疗效以及预后成为关注焦点，因此研究SUVmax值用于评价NSCLC放疗1年局部控制率的意义。
出处
《中华放射肿瘤学杂志》
CSCD
北大核心
2009年第2期123-124,共2页
Chinese Journal of Radiation Oncology
参考文献10
-
1Vansteenkiste JF, Stroobants SG, Dupont PJ, et al. Prognostic importance of the standardized uptake value on( 18 )F-fluoro-2-deoxyglucose-positron emission tomography scan in non-small-cell lung cancer: an analysis of 125 cases. Leuven Lung Cancer Group. J Clin Oncol, 1999,17:3201-3206.
-
2Young H, Baum R, Cremerius U, et al. Measurement of clinical and subclinical tumour response using [ 18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer(EORTC) PET Study Group. Eur J Cancer, 1999,35 : 1773-1782.
-
3Mountain CF. Revisions in the international system for staging lung cancer. Chest, 1997,111 : 1710-1717.
-
4Berghmans T, Dusart M, Paesmans M, et al. Primary tumor standardized uptake value ( SUVmax ) measured on fluorodeoxyglucose positron emission tomography(FDG-PET) is of prognostic value for survival in non-small cell lung cancer( NSCLC ) : a systematic review and meta-analysis(MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project. J Thorac On- col ,2008,3:6-12.
-
5de Jong WK, van der Heijden HF, Pruim J, et al. Prognostic value of different metabolic measurements with fluorine-18 fluorodeoxyglucose positron emission tomography in resectable non-small cell lung cancer: a two-center study. J Thorac 0ncol,2007,2 : 1007- 1012.
-
6Wong CY, Schmidt J, Bong JS, et al. Correlating metabolic and anatomic responses of primary lung cancers to radiotherapy by combined F-18 FDG PET-CT imaging. Radiat Oncol,2007,2 : 18.
-
7Dooms C,Verbeken E, Stroobants S,et al. Prognostic stratification of stage ⅢA-N2 non-small-cell lung cancer after induction chemotherapy : a model based on the combination of morphometric-pathologic response in mediastinal nodes and primary tumor response on serial 18-fluoro-2-deoxy-glucose positron emission tomography. J Clin Onco1,2008,26 : 1128-1134.
-
8Hoekstra C J, Stroobants SG, Smit EF, et al. Prognostic relevance of response evaluation using [ 18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced nonsmall-cell lung cancer. J Clin Oncol,2005,23:8362-8370.
-
9Pottgen C, Levegrun S, Theegarten D, et al. Value of 18 F-fluoro-2- deoxy-D-giucose-positron emission tomography/computed tomography in non-small-cell lung cancer for prediction of pathologic response and times to relapse after neoadjuvant chemoradiotherapy. Clin Cancer Res,2006 ,12 :97-106.
-
10Cerfolio R J, Bryant AS, Ojha B. Restaging patients with N2 ( stage Ⅲ a) non-small cell lung cancer after neoadjuvant chemoradiotherapy: a prospective study. J Thorac Cardiovasc Surg, 2006,131: 1229-1235.
-
1冯梅.胰腺癌,悄悄作案的“隐秘杀手”[J].药物与人,2008(4):10-12.
-
2佘志文,吴宜林.卵巢交界性肿瘤治疗进展[J].国外医学（肿瘤学分册）,2005,32(4):307-309. 被引量：1
-
3吴立丽,王娟,刘奎甲,张宏涛,赵静,高贞,李健敏.放射性125I粒子总活度与肿瘤体积的关系[J].中华实验外科杂志,2012,29(12):2428-2428.
-
4高砚春,吴诚义.乳腺癌新辅助化疗研究的新进展[J].中国普通外科杂志,2004,13(11):846-849. 被引量：6
-
5李连贺,谭福宪,岳文慧,王红梅,王洪敏,薛浩,温振雷.影响TPF方案治疗下咽癌患者疗效的临床因素分析[J].临床耳鼻咽喉头颈外科杂志,2015,29(19):1705-1707. 被引量：1
-
6师英强,黄恺,陈治宇.靶向治疗在胃肠道间质瘤中的应用[J].中国癌症杂志,2009,19(6):409-411. 被引量：4
-
7谈芸,邹绍钱（摘）.低镁饮食导致“病从口入”[J].健康文摘,2006(5):31-31.
-
8王俊珊,卢洁,周莹群,郭传勇.索拉菲尼及几种靶向药物的肝癌治疗评价[J].世界临床药物,2015,36(6):361-365. 被引量：2
-
9季彤.口腔颌面肿瘤患者的修复重建与生存质量[J].国际口腔医学杂志,2004,32(S1):92-93.
-
10张龙江,杨亚英,祁吉,沈文.胃肠道间质瘤的影像表现与病理对照研究[J].中华放射学杂志,2007,41(6):607-610. 被引量：29
